Laman Utama1099 • HKG
add
Sinopharm Group Co Ltd
Tutup sebelumnya
$18.30
Julat hari
$18.22 - $18.42
Julat tahun
$16.02 - $23.65
Permodalan pasaran
57.36B HKD
Bilangan Purata
8.44J
Nisbah P/E
7.56
Hasil dividen
3.97%
Pertukaran utama
HKG
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CNY) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 141.66B | -3.81% |
Perbelanjaan pengendalian | 6.72B | -6.59% |
Pendapatan bersih | 1.46B | 2.59% |
Margin untung bersih | 1.03 | 7.29% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 3.70B | -5.19% |
Kadar cukai berkesan | 23.38% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CNY) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 45.36B | -32.44% |
Jumlah aset | 415.08B | — |
Jumlah liabiliti | 285.93B | — |
Jumlah ekuiti | 129.16B | — |
Syer tertunggak | 3.12B | — |
Harga kepada buku | 0.71 | — |
Pulangan pada aset | 1.96% | — |
Pulangan pada modal | 3.85% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CNY) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 1.46B | 2.59% |
Tunai daripada operasi | -34.28B | 27.81% |
Tunai daripada pelaburan | 617.49J | 141.09% |
Tunai daripada pembiayaan | 12.88B | -41.88% |
Perubahan bersih dalam tunai | -20.78B | 17.10% |
Aliran tunai bebas | -14.13B | — |
Perihal
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Diasaskan
2003
Tapak web
Pekerja
108,217
